Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Liabilities and Shareholders Equity: 2023

Historic Liabilities and Shareholders Equity for Sagimet Biosciences (SGMT) over the last 1 years, with Dec 2023 value amounting to $96.7 million.

  • Sagimet Biosciences' Liabilities and Shareholders Equity rose 69.81% to $174.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $655.0 million, marking a year-over-year change of. This contributed to the annual value of $96.7 million for FY2023, which is N/A change from last year.
  • Sagimet Biosciences' Liabilities and Shareholders Equity amounted to $96.7 million in FY2023.
  • Over the past 5 years, Sagimet Biosciences' Liabilities and Shareholders Equity peaked at $96.7 million during FY2023, and registered a low of $96.7 million during FY2023.
  • For the 1-year period, Sagimet Biosciences' Liabilities and Shareholders Equity averaged around $96.7 million, with its median value being $96.7 million (2023).